Insider · CIK 0001410466
Steven Love
Files at OABI (OmniAb, Inc.). First filing May 14, 2025, latest May 14, 2025.
In brief
Steven Love files SEC Form 4 as director at OABI (OmniAb, Inc.). Since May 14, 2025, Steven Love has reported 1 open-market buy worth $37k and 0 open-market sells worth $0, the latest filed on May 14, 2025.
A track record needs three past buys with six months of prices behind them; Steven Love has 0, so none is measured yet.
The newest scored trade: bought $37k of OABI on May 14, 2025, filed May 14, 2025, scored 64 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OABI: OmniAb, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 64Notable | OmniAb, Inc. | $37k 25,000 shares | +188% | +9% from low-68% from high |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | OABI OmniAb, Inc. | MOption exercise Common Stock | +20,000 | - | - | 91,666 | Jun 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -20,000 | $0.00 | $0 | 13,334 | Jun 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | AGrant or award Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 33,334 | Jun 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 18, 2026 |
| Nov 1, 2025 | OABI OmniAb, Inc. | MOption exercise Common Stock | +13,333 | - | - | 71,666 | Nov 3, 2025 |
| Nov 1, 2025 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -13,333 | $0.00 | $0 | 33,334 | Nov 3, 2025 |
| Jun 17, 2025 | OABI OmniAb, Inc. | MOption exercise Common Stock | +20,000 | - | - | 58,333 | Jun 18, 2025 |
| Jun 17, 2025 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -20,000 | $0.00 | $0 | 26,667 | Jun 18, 2025 |
| Jun 17, 2025 | OABI OmniAb, Inc. | AGrant or award Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 46,667 | Jun 18, 2025 |
| Jun 17, 2025 | OABI OmniAb, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 18, 2025 |
| May 14, 2025 | OABI OmniAb, Inc. | POpen-market purchase Common Stock | +25,000 | $1.46 | $37k | 38,333 | May 14, 2025 |
| Nov 1, 2024 | OABI OmniAb, Inc. | MOption exercise Common Stock | +13,333 | - | - | 13,333 | Nov 1, 2024 |
| Nov 1, 2024 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -13,333 | $0.00 | $0 | 46,667 | Nov 1, 2024 |
| Nov 1, 2023 | OABI OmniAb, Inc. | AGrant or award Restricted Stock Unitsderivative | +40,000 | $0.00 | $0 | 40,000 | Nov 2, 2023 |
| Nov 1, 2023 | OABI OmniAb, Inc. | AGrant or award Stock Option (right to buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Nov 2, 2023 |
Questions about Steven Love
Answered from the filings on this page, as of the latest one.
Is Steven Love buying or selling?
Not in the last 12 months. Steven Love's latest open-market trade on SEC Form 4 was bought $37k of OABI on May 14, 2025.
How did Steven Love's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven Love has 0.
Where does Steven Love file Form 4?
Steven Love has filed Form 4 at OABI (OmniAb, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.